Nanogen and Prodesse to Collaborate on Infectious Disease Tests | GenomeWeb

NEW YORK, Sept. 10 (GenomeWeb News) - Nanogen and Prodesse announced today a collaboration to develop microarray-based tests for infectious disease agents such as influenza, West Nile virus, and SARS.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.